Government-owned Breakthrough Victoria is tipping $100 million in pre-seed funding into startups at the state’s universities looking to commercialise research. Premier Dan Andrews and treasurer Tim Pallas set up the $2 billion Breakthrough Victoria fund, chaired by former premier John Bracks, as an independent investment fund manager investing in commercial innovations in health, technology, manufacturing,… Read more »
The federal government is spending $1.6 billion over 10 years to take university research across the ‘valley of death’ to commercialisation
The federal government is investing $2.2 billion for university research commercialisation which would place “university innovation and industry collaboration front and centre of Australia’s economic recovery.” Part of this funding includes $1.6 billion over ten years for Australia’s Economic Accelerator – a new competitive funding program to help university projects bridge the so-called “valley of… Read more »
Australia’s new $40 million biotech incubator, CUREator, is on the hunt for researchers and startup founders
Expressions of interest are now open for the first cohort for CUREator, Australia’s first national biotech incubator. CUREator was established with $40 million in funding from the federal government’s Medical Research Future Fund (MRFF) and the incubator, run by the Brandon Capital-managed Medical Research Commercialisation Fund (MRCF), hopes to play a hand in developing up… Read more »
A national biotech incubator is being set up in an Australia first following a $40 million grant from the federal government’s Medical Research Future Fund (MRFF) The incubator will be run by the Brandon Capital-managed Medical Research Commercialisation Fund (MRCF), which received the grant as part of $79 million in MRFF commercialisation grants to four… Read more »
A battery materials company promising to improve the capacity of existing lithium-ion batteries by up to 100% has raised $3.7 million in a pre-Series A. The round was led by local VC Artesian and US-based Riverstone Ventures, with New York’s Chaos Ventures, Singapore’s SDGx and Sydney VC Bandera Capital also chipping in alongside several prominent Australian… Read more »
The NSW government’s health department has turned once again to deep tech incubator Cicada Innovations to deliver a free training program to help aspiring biotech and medtech entrepreneurs and academics commercialise their ideas. The NSW Health Commercialisation Training Program aims to fast-track innovative ideas that will revolutionise the healthcare sector, improve patient outcomes, and provide… Read more »
It took a chance meeting between Cameron van den Dungen, founder of a start-up mattress company, and Madhu Bhaskaran, an engineering professor at RMIT University, to see an opportunity to collaborate and commercialise research. Van den Dungen had a dream of creating a bed for use in aged care to monitor sleep quality and comfort.… Read more »
ESN Cleer CEO Leopoldt de Bruin and Professor Sharath Sriram. A Melbourne startup has developed a life-saving hand-held device to predict heart failure based on saliva that could be available to the public within two years The device uses nano-sensors on a diagnostic stick to measure heart disease biomarkers from saliva to accurately predict… Read more »
A new biotech funding program for startups working on new therapies, technologies and medical devices is offering up to $1 million in matching grants to help companies develop their ideas through to the proof of concept stage. The Biomedical Translation Bridge program is an initiative of the Medical Research Future Fund. It’s run by MTPConnect –… Read more »
Australian VC firm, Brandon Capital Partners, has just raised another $210 million to invest in commercialising medical research, and is already on the hunt for another $250 million as it edges towards $1 billion in science investments. The 5th Medical Research Commercialisation Fund, MRCF5, raised AU$210 million from existing investors, taking the total in the… Read more »
Dedicated to identifying the most promising research from universities across New Zealand and Australia, forming a company around it, investing in it, and commercialising it is Powerhouse Ventures.
Bionic Vision Technologies a company working to create a ‘bionic eye’, has raised $23.5 million China Huarong International Holdings and State Path Capital.
The government has launched the Biomedical Translation Fund, a $500 million fund that will help commercialise biomedical discoveries.